MassDevice.com +5 | The top 5 medtech stories for March 17, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. GlucoMe tackles connected diabetes management with acoustic data transmission The Centers for Disease Control & Prevention predict that by 2050, if current trends continue, 1 in 3 adults in the U.S. will have diabetes. The digital diabetes management company GlucoMe hopes it can develop a smarter healthcare model t0 fit this growing patient population. “Diabetes is an inter-world epidemic – a pandemic – and the number of patients is constantly increasing,” co-founder & CEO Yiftah Ben Aharon told Drug Delivery Business News. “So, it doesn’t make sense to keep the current treatment model and current care model the same.” Read more 4. Penumbra prices $99m offering Penumbra said today that it priced a public offering worth nearly $99 million, not including an underwriter’s option worth nearly $15 million. Alameda, Calif.-based Penumbra makes a line of instruments designed for neurovascular and peripheral vascular procedures, including stroke revascularization, embolization and thrombectomy. Read more 3. Boston Scientific touts 3-year outcomes for Synergy bi...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news